ICI-200880

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameICI-200880
Drug Alias NameICI-200880
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte elastase inhibitors
TargetsLeukocyte elastase
Therapy Area/IndicationsEmphysemaMyocardial IschemiaRespiratory Distress Syndrome, Newborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsEmphysemaMyocardial IschemiaRespiratory Distress Syndrome, Newborn

Other Information

ATC CodeN/A
Related LinksN/A